Pertussis: Old foe, persistent problem

Cleveland Clinic Journal of Medicine

Volumn 72, Issue 7, 2005, Pages 601-608

  Sabella, Camille ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACELLULAR VACCINE; AZITHROMYCIN; COTRIMOXAZOLE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; ERYTHROMYCIN ESTOLATE; HEPATITIS A VACCINE; MACROLIDE; OXYGEN; PERTUSSIS VACCINE; PLACEBO;

BACTERIAL IMMUNITY; BACTERIAL TRANSMISSION; BACTERIUM CULTURE; BORDETELLA PERTUSSIS; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; DIPHTHERIA; DISEASE COURSE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; EDEMA; EPIDEMIC; FATALITY; FLUORESCENT ANTIBODY TECHNIQUE; HIGH RISK POPULATION; HUMAN; IMMUNIZATION; IMMUNOGENICITY; INCIDENCE; INFECTION PREVENTION; INFECTION RISK; INFECTION SENSITIVITY; LIMB SWELLING; MORBIDITY; MORTALITY; OXYGEN THERAPY; PERTUSSIS; POLYMERASE CHAIN REACTION; PREVALENCE; REVIEW; SENSITIVITY ANALYSIS; SERODIAGNOSIS; SYSTEMIC DISEASE; TETANUS; VACCINATION;

EID: 22944446465     PISSN: 08911150     EISSN: None     Source Type: Journal    
DOI: 10.3949/ccjm.72.7.601     Document Type: Review

References (38)

1. Cherry JD, Brunell PA, Golden GS, Karzon DT. Report of the Task Force on Pertussis and Pertussis Immunization - 1988. Pediatrics 1988; 81(suppl):933-984.
2. Davis SF, Strebel PM, Cochi SL, Zell ER, Hadler SC. Pertussis surveillance - United States, 1989-1991. MMWR CDC Surveill Summ 1992; 41:11-19.
3. Rosenthal S, Strebel P, Cassiday P, Sanden G, Brusuelas K, Wharton M. Pertussis infection among adults during the 1993 outbreak in Chicago. J Infect Dis 1995; 171:1650-1652.
4. Christie CD, Marx ML, Marchant CD, Reising SF. The 1993 epidemic of pertussis in Cincinnati. Resurgence of disease in a highly immunized population of children. N Engl J Med 1994; 331:16-21.
5. Halperin SA, Bortolussi R, MacLean D, Chisholm N. Persistence of pertussis in an immunized population: results of the Nova Scotia Enhanced Pertussis Surveillance Program. J Pediatr 1989; 115:686-693.
6. Pertussis. In: Epidemiology and prevention of vaccine-preventable diseases [electronic resource]: course textbook. 8th ed. Atlanta, Ga: Centers for Disease Control and Prevention, National Immunization Program; 2005:75-88. Available at: www.cdc.gov/nip/publications/pink/pert.pdf. Accessed May 11, 2005.
7. World Health Organization. Global and regional summaries. In: WHO vaccine-preventable diseases: monitoring system. 2004 Global Summary. Geneva, Switzerland, 2004:26. www.who.int/vaccines-documents/GlobalSummary/GlobalSummary.pdf. Accessed May 12, 2005.
8. Guris D, Strebel PM, Bardenheier B, et al. Changing epidemiology of pertussis in the United States: increasing reported incidence among adolescents and adults, 1990-1996. Clin Infect Dis 1999; 28:1230-1237.
9. Farizo KM, Cochi SL, Zell ER, Brink EW, Wassilak SG, Patriarca PA. Epidemiologic features of pertussis in the United States, 1980-1989. Clin Infect Dis 1992; 14:708-719.
10. Tozzi AE, Rava L, Ciofi degli Atti ML, Salmaso S; Progetto Pertosse Working Group. Clinical presentation of pertussis in unvaccinated and vaccinated children in the first six years of life. Pediatrics 2003; 112:1069-1075.
11. Long SS, Welkon CJ, Clark JL. Widespread silent transmission of pertussis in families: antibody correlates of infection and symptomatology. J Infect Dis 1990; 161:480-486.
12. He Q, Viljanen MK, Nikkari S, Lyytikainen R, Mertsola J. Outcomes of Bordetella pertussis infection in different age groups of an immunized population. J Infect Dis 1994; 170:873-877.
13. Long SS, Edwards KM. Bordetella pertussis (Pertussis) and other species. In: Long SS, Pickering LK, Prober CG, editors. Principles and Practice of Pediatric Infectious Diseases. 2nd ed. New York, NY: Churchill Livingstone; 2003:880-888.
14. Pertussis - United States, 1997-2000. MMWR Morb Mortal Wkly Rep 2002; 51:73-76.
15. Strebel P, Nordin J, Edwards K, et al. Population-based incidence of pertussis among adolescents and adults, Minnesota, 1995-1996. J Infect Dis 2001; 183:1353-1359. Epub 2001 Mar 30.
16. Senzilet LD, Halperin SA, Spika JS, Alagaratnam M, Morris A, Smith B; Sentinel Health Unit Surveillance System Pertussis Working Group. Pertussis is a frequent cause of prolonged cough illness in adults and adolescents. Clin Infect Dis 2001; 32:1691-1697. Epub 2001 May 21.
17. Deen JL, Mink CA, Cherry JD, et al. Household contact study of Bordetella pertussis infections. Clin Infect Dis 1995; 21:1211-1219.
18. Cherry JD. Epidemiological, clinical, and laboratory aspects of pertussis in adults. Clin Infect Dis 1999; 28:S112-S117.
19. Heininger U, Klich K, Stehr K, Cherry JD. Clinical findings in Bordetella pertussis infections: results of a prospective multicenter surveillance study. Pediatrics 1997; 100:E10.
20. Hallander HO. Microbiological and serological diagnosis of pertussis. Clin Infect Dis 1999; 28:S99-S106.
21. Edelman K, Nikkari S, Ruuskanen O, He Q, Viljanen M, Mertsola J. Detection of Bordetella pertussis by polymerase chain reaction and culture in the nasopharynx of erythromycin-treated infants with pertussis. Pediatr Infect Dis J 1996; 15:54-57.
22. Heininger U, Schmidt-Schlapfer G, Cherry JD, Stehr K. Clinical validation of a polymerase chain reaction assay for the diagnosis of pertussis by comparison with serology, culture, and symptoms during a large pertussis vaccine efficacy trial. Pediatrics 2000; 105:E31.
23. van der Zee A, Agterberg C, Peeters M, Mooi F, Schellekens J. A clinical validation of Bordetella pertussis and Bordetella parapertussis polymerase chain reaction: comparison with culture and serology using samples from patients with suspected whooping cough from a highly immunized population. J Infect Dis 1996; 174:89-96.
24. Edwards KM. Is pertussis a frequent cause of cough in adolescents and adults? Should routine pertussis immunization be recommended? Clin Infect Dis 2001; 32:1698-1699. Epub 2001 May 21.
25. Bergquist SO, Bernander S, Dahnsjo H, Sundelof B. Erythromycin in the treatment of pertussis: a study of bacteriologic and clinical effects. Pediatr Infect Dis J 1987; 6:458-461. Erratum in: Pediatr Infect Dis J 1987; 6:1035.
26. Langley JM, Halperin SA, Boucher FD, Smith B; Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC). Azithromycin is as effective as and better tolerated than erythromycin estolate for the treatment of pertussis. Pediatrics 2004; 114:e96-e101.
27. Halperin SA, Bortolussi R, Langley JM, Eastwood BJ, De Serres G. A randomized, placebo-controlled trial of erythromycin estolate chemoprophylaxis for household contacts of children with culture-positive Bordetella pertussis infection. Pediatrics 1999; 104:e42.
28. De Serres G, Boulianne N, Duval B. Field effectiveness of erythromycin prophylaxis to prevent pertussis within families. Pediatr Infect Dis J 1995; 14:969-975.
29. Weber DJ, Rutala WA. Management of healthcare workers exposed to pertussis. Infect Control Hosp Epidemiol 1994; 15:411-415.
30. Volk VK, Gottshall RY, Anderson HD, Top FH, Bunney WE, Serfling RE. Antibody response to booster dose of diphtheria and tetanus toxoids and pertussis vaccine. Public Health Rep 1964; 79:424-434.
31. Linnemann CC Jr, Ramundo N, Perlstein PH, Minton SD, Englender GS. Use of pertussis vaccine in an epidemic involving hospital staff. Lancet 1975; 2:540-543.
32. Keitel WA, Muenz LR, Decker MD, et al. A randomized clinical trial of acellular pertussis vaccines in healthy adults: dose-response comparisons of 5 vaccines and implications for booster immunization. J Infect Dis 1999; 180:397-403.
33. Edwards KM, Decker MD, Graham BS, Mezzatesta J, Scott J, Hackell J. Adult immunization with acellular pertussis vaccine. JAMA 1993; 269:53-56.
34. Ward J. Acellular pertussis vaccines in adolescents and adults [abstract 1291]. In: Abstracts of the 41st Interscience Conference on Antimicrobial Agents and Chemotherapy, December 16-19, 2001, Chicago, IL:520.
35. Le T, Cherry JD, Chang SJ, et al. Immune responses and antibody decay after immunization of adolescents and adults with an acellular pertussis vaccine: the APERT Study. J Infect Dis 2004; 190:535-544. Epub 2004 Jul 7.
36. Edelman KJ, He Q, Makinen JP, et al. Pertussis-specific cell-mediated and humoral immunity in adolescents 3 years after booster immunization with acellular pertussis vaccine. Clin Infect Dis 2004; 39:179-185. Epub 2004 Jul 2.
37. Rennels MB, Deloria MA, Pichichero ME, et al. Extensive swelling after booster doses of acellular pertussis-tetanus-diphtheria vaccines. Pediatrics 2000; 105:e12.
38. Purdy KW, Hay JW, Botteman MF, Ward JI. Evaluation of strategies for use of acellular pertussis vaccine in adolescents and adults: a cost-benefit analysis. Clin Infect Dis 2004; 39:20-28. Epub 2004 Jun 14.